The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 348:138-150 January 9, 2003 Number 2
NextNext

The Pathophysiology and Treatment of Sepsis
Richard S. Hotchkiss, M.D., and Irene E. Karl, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Sepsis is the leading cause of death in critically ill patients in the United States. Sepsis develops in 750,000 people annually, and more than 210,000 of them die.1,2 After numerous unsuccessful trials of antiinflammatory agents in patients with sepsis, investigators doubted that mortality could be decreased. Advances in unraveling the pathophysiology and genetic basis for the host response to sepsis have changed the prevailing understanding of the syndrome, and several therapies have demonstrated surprising efficacy. In this article, we examine evolving concepts of sepsis and discuss new and potential therapies.

A Disorder Due to Uncontrolled Inflammation?

The prevailing theory has been that sepsis represents an uncontrolled . . . [Full Text of this Article]

Failure of the Immune System?

Mechanisms of Immune Suppression in Sepsis

A Shift to Antiinflammatory Cytokines

Anergy

Death of Immune Cells

Reappraisal of Lewis Thomas's Theory

Host Genetic Factors

Surprising Insights about Neutrophils

Lessons from Autopsy Studies

Cellular Hibernation as a Mechanism of Organ Dysfunction

Death of Patients with Sepsis

New Concepts in the Treatment of Sepsis

Activated Protein C

Intensive Insulin Therapy for Hyperglycemia

Volume Resuscitation

Corticosteroids

An Emerging Concept of the Nature of the Immune Response in Sepsis

Potential Therapies for Sepsis

Conclusions


Source Information

From the Departments of Anesthesiology (R.S.H.), Medicine (R.S.H., I.E.K.), and Surgery (R.S.H.), Washington University School of Medicine, St. Louis.

Address reprint requests to Dr. Hotchkiss at the Department of Anesthesiology, Washington University School of Medicine, Campus Box 8054, St. Louis, MO 63110, or at hotch@morpheus.wustl.edu.


Related Letters:

Sepsis — Theory and Therapies
Ronco C., Bellomo R., Lonneman G., Agarwal P. K., Kumari R., Netea M. G., Van der Meer J. W., Kullberg B. J., Hotchkiss R. S., Karl I. E.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1600-1602, Apr 17, 2003. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.